Business Development

Cortendo has pioneered cortisol inhibition as a treatment for Metabolic Syndrome (MES) and is dedicated to this therapeutic area.

The company can offer out-licensing opportunities for proprietary technologies and programs and Cortendo will also search for innovative technologies and product candidates that may supplement in-house projects.

Cortendo is also interested in research collaborations with academic groups and biotech companies. The company might be able to provide technologies and know-how that your organization can use to explore scientific arenas beyond your available resources and skills.

For more information, please contact us at: bd@cortendo.com